Practical limitations of prescribing olanzapine depot (Relprevv).
Devadason
Peter
P
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001315:Australia; D001569:Benzodiazepines / Q000008:administration & dosage* / Q000009:adverse effects*; D003134:Commitment of Persons with Psychiatric Disorders; D003692:Delayed-Action Preparations; D006300:Health Services Misuse; D006801:Humans; D007273:Injections, Intramuscular; D007318:Inservice Training / Q000458:organization & administration; D008991:Monitoring, Physiologic; D009520:New Zealand; D000077152:Olanzapine; D010348:Patient Care Team; D010349:Patient Compliance / Q000523:psychology; D011567:Psychiatric Department, Hospital; D011568:Psychiatric Nursing / Q000193:education; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000451:nursing / Q000523:psychology; D012151:Resuscitation / Q000451:nursing
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D001569:Benzodiazepines; D000077152:Olanzapine